Abstract

Memory T cells primed against microbial antigen can cross-react with allogeneic antigen and mediate graft rejection, a process termed heterologous immunity. This scenario requires the T cell receptor (TCR) to recognize both the priming microbial peptide:MHC (pMHC) and an allogeneic pMHC complex, distinct binding interactions that likely have different magnitudes of TCR:pMHC affinity. However, the role that TCR affinity plays during heterologous immunity is unknown. To investigate the impact of TCR affinity during heterologous immune responses, we utilized a model in which transgenic CD8+ T cells are primed via pathogen infection with either high affinity or low affinity antigen, and are subsequently challenged with a skin allograft that constitutively expresses high affinity antigen. Our results demonstrate that infections with high and low affinity antigen generated a similar frequency of KLRG-1lowCD127high memory precursor cells. However, compared to high affinity memory cells, a greater proportion of low affinity memory cells became CD44highCD62Lhigh TCM. Furthermore, the low affinity memory population contained significantly more TNF+ and TNF+IFN-g+ double producer cells when rechallenged with high affinity antigen. Surprisingly, low affinity primed memory CD8+ T cells rejected skin allografts with faster kinetics than high affinity memory CD8+ T cells and were resistant to a costimulation/integrin blockade regimen. We next sought to understand the mechanistic basis underlying this increased potency of low affinity memory CD8+ T cells. High and low affinity memory cells expressed similar levels of TCR, CD8, and CD5; however, low affinity memory cells were predominantly CD45RBhigh, suggesting that CD45RB expression may tune low affinity memory CD8+ T cells to optimally respond to antigen with a broad range of affinity. These studies reveal an important role for low affinity memory CD8+ T cells during graft rejection in the context of heterologous immunity, and identify the phenotypic and functional characteristics associated with their increased potency in vivo.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call